Helius Medical Technologies Inc [HSDT] moved down -4.39: Why It’s Important

GBS Stock

Helius Medical Technologies Inc [NASDAQ: HSDT] plunged by -$0.05 during the normal trading session on while it closed the day at $1.09.

Helius Medical Technologies Inc stock has also loss -73.38% of its value over the past 7 days. However, HSDT stock has declined by -83.85% in the 3 months of the year. Over the past six months meanwhile, it has lost -88.99% and lost -89.16% year-on date.

The market cap for HSDT stock reached $0.58 million, with 0.53 million shares outstanding and 0.52 million shares in the current float. Compared to the average trading volume of 482.02K shares, HSDT reached a trading volume of 15305211 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Helius Medical Technologies Inc [HSDT]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HSDT shares is $60.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HSDT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Noble Capital Markets have made an estimate for Helius Medical Technologies Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 24, 2021.

The Average True Range (ATR) for Helius Medical Technologies Inc is set at 0.61, with the Price to Sales ratio for HSDT stock in the period of the last 12 months amounting to 1.35. The Price to Book ratio for the last quarter was 0.35, with the Price to Cash per share for the same quarter was set at 2.09.

HSDT stock trade performance evaluation

Helius Medical Technologies Inc [HSDT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -73.38. With this latest performance, HSDT shares dropped by -73.86% in over the last four-week period, additionally sinking by -88.99% over the last 6 months – not to mention a drop of -94.45% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HSDT stock in for the last two-week period is set at 21.25, with the RSI for the last a single of trading hit 15.93, and the three-weeks RSI is set at 25.65 for Helius Medical Technologies Inc [HSDT]. The present Moving Average for the last 50 days of trading for this stock 4.3781, while it was recorded at 2.5350 for the last single week of trading, and 7.9081 for the last 200 days.

Helius Medical Technologies Inc [HSDT]: An insightful look at the core fundamentals

Helius Medical Technologies Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.13 and a Current Ratio set at 1.69.

Helius Medical Technologies Inc [HSDT]: Institutional Ownership

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.